| 摘要 |
The present invention relates to a composition and method for therapeutic treatment of humans and other mammals. The therapeutic composition of the present invention comprises an encapsulation vesicle, an activation agent such as a nanotube associated with the encapsulation vesicle, a bioactive agent, and an optional targeting ligand. The targeting ligand may be attached to either the activation agent or the encapsulation vesicle. The encapsulation vesicle selectively releases the bioactive agent to achieve a targeted application of the therapeutic or diagnostic potential for the bioactive agent, such as to destroy a diseased cell. The activation agent is activated by an endogenous or exogenous activation condition. |
